Cargando…

Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection

A study by Kitchin, Richardson et al. finds that breakthrough infection with the SARS-CoV-2 Delta variant in Ad26.COV2.S-vaccinated individuals induces strong neutralizing antibody responses against multiple variants, including the Omicron variant.

Detalles Bibliográficos
Autor principal:	Montefiori, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Preview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922435/ https://www.ncbi.nlm.nih.gov/pubmed/35474738 http://dx.doi.org/10.1016/j.xcrm.2022.100579

Ejemplares similares

Getting to the (germinal) center of humoral immune responses to SARS-CoV-2
por: Tangye, Stuart G., et al.
Publicado: (2022)

SARS-CoV-2 infection of islet β cells: Evidence and implications
por: Clark, Amy L., et al.
Publicado: (2021)

Immune imprinting as a barrier to effective COVID-19 vaccines
por: Faraone, Julia N., et al.
Publicado: (2023)

Getting in on the action: New tools to see SARS-CoV-2 infect a cell
por: Hansen, Scott B., et al.
Publicado: (2023)

Illuminating the Fc dependence of SARS-CoV-2 neutralization
por: González, Joseph C., et al.
Publicado: (2021)

Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
por: Griffiths, Elizabeth A., et al.
Publicado: (2021)

SARS-CoV-2 RNA: Exclusive friends and common foes
por: LeBlanc, Emmanuelle V., et al.
Publicado: (2021)

Snatching the Crown from SARS-CoV-2
por: Coughlan, Lynda
Publicado: (2020)

SARS-CoV-2: Combating Coronavirus Emergence
por: Graham, Rachel L., et al.
Publicado: (2020)

Autophagosome maturation stymied by SARS-CoV-2
por: Yim, Willa Wen-You, et al.
Publicado: (2021)

The continuing search for the origins of SARS-CoV-2
por: Karlsson, Erik A., et al.
Publicado: (2021)

Order and disorder bound together in SARS-CoV-2 Nsp1 suppress host translation
por: Libich, David S., et al.
Publicado: (2023)

Mining the Antibody Repertoire for Solutions to SARS-CoV-2
por: Meng, Wenzhao, et al.
Publicado: (2020)

A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates
por: LeBlanc, Emmanuelle V., et al.
Publicado: (2021)

Virus hunters: Discovering the evolutionary origins of SARS-CoV-2
por: Banerjee, Arinjay
Publicado: (2021)

Hold your horses: The receptor-binding domains of SARS-CoV-2, SARS-CoV, and hCoV-NL63 bind equine ACE2
por: Nawrath, Philipp, et al.
Publicado: (2022)

SARS-CoV-2 pirates the kidneys: A scar(y) story
por: Reiser, Jochen, et al.
Publicado: (2022)

A Crisp(r) New Perspective on SARS-CoV-2 Biology
por: Bailey, Adam L., et al.
Publicado: (2021)

FRETing over SARS-CoV-2: Conformational Dynamics of the Spike Glycoprotein
por: Serrão, Vitor Hugo B., et al.
Publicado: (2020)

The great escape? SARS-CoV-2 variants evading neutralizing responses
por: Prévost, Jérémie, et al.
Publicado: (2021)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Ad26.cov2-s/elasomeran/tozinameran: Vaccine breakthrough infection: 76 case reports
Publicado: (2022)

Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury
por: Tabassum, Neha, et al.
Publicado: (2020)

Of variants and vaccines
por: Grubaugh, Nathan D., et al.
Publicado: (2021)

A point-of-care biosensor for rapid and ultra-sensitive detection of SARS-CoV-2
por: Zhou, Xinyuan, et al.
Publicado: (2022)

Uncovering the complexities of biological structures with network-based learning: An application in SARS-CoV-2
por: Faghri, Faraz, et al.
Publicado: (2021)

Versatile use of bat ACE2 for cellular entry by MERS-CoV-like viruses
por: Baid, Kaushal, et al.
Publicado: (2023)

Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks
por: Joyce, M. Gordon, et al.
Publicado: (2020)

Rafting through the palms: S-acylation of SARS-CoV-2 spike protein induces lipid reorganization
por: Vilmen, Geraldine, et al.
Publicado: (2021)

Fc effector cross-reactivity: A hidden arsenal against SARS-CoV-2’s evasive maneuvering
por: Grunst, Michael W., et al.
Publicado: (2022)

Q fever vaccine development: Challenges and progress in balancing safety and efficacy
por: Sluder, Ann E., et al.
Publicado: (2021)

Holy Immune Tolerance, Batman!
por: Randolph, Haley E., et al.
Publicado: (2018)

Teach ‘em young: Influenza vaccines induce broadly neutralizing antibodies in children
por: Dugan, Haley L., et al.
Publicado: (2022)

Zebrafishing for enhancers of hearing regeneration
por: Echeverri, Karen
Publicado: (2022)

Omicron’s message on vaccines: Boosting begets breadth
por: Wesemann, Duane R.
Publicado: (2022)

Unwanted Feedback: Malaria Antibodies Hinder Vaccine Boosting
por: Coelho, Camila H., et al.
Publicado: (2020)

Co-dominant neutralizing epitopes make anti-measles immunity resistant to viral evolution
por: Greaney, Allison J., et al.
Publicado: (2021)

Predicting patient-specific enhancer-promoter interactions
por: Baur, Brittany, et al.
Publicado: (2023)

Toward the development of a protein-based group B Streptococcus vaccine
por: Dominguez, Kristen, et al.
Publicado: (2022)

New insights about immune populations in gastrointestinal GvHD
por: Hayase, Eiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gpjfc4vc8kmp55j1q3qfvjoko2